Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)

.

Source: Expert Opinion on Biological Therapy - April 17, 2023 Category: Drugs & Pharmacology Authors: Bernd Bokemeyer Tibor Hlavaty Matthieu Allez Pamela Selema Shahrzad Moosavi Mary Jane Cadatal Heather Fowler Markus Mueller Katherine F Liau Javier P Gisbert Source Type: research